Amanote Research
Register
Sign In
Re-Evaluation of Direct Hemoperfusion With Polymyxin-B Immobilized Fiber for Severe Sepsis and Septic Shock
Critical Care
- United Kingdom
doi 10.1186/cc9540
Full Text
Open PDF
Abstract
Available in
full text
Categories
Critical Care
Intensive Care Medicine
Date
January 1, 2011
Authors
SM Matsuo
TI Ikeda
KI Ikeda
Publisher
Springer Science and Business Media LLC
Related search
Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients With Septic Shock
Journal of Nippon Medical School
Medicine
Improved Outcome of Septic Shock Patients Treated Without Polymyxin B Hemoperfusion
Nihon Kyukyu Igakukai Zasshi
Polymyxin B Hemoperfusion in High Endotoxin Activity Level Septic Shock Patients
Critical Care
Critical Care
Intensive Care Medicine
Correction To: Polymyxin B-Immobilized Hemoperfusion and Mortality in Critically Ill Adult Patients With Sepsis/Septic Shock: A Systematic Review With Meta-Analysis and Trial Sequential Analysis
Intensive Care Medicine
Critical Care
Intensive Care Medicine
The Effect of Endotoxin Adsorber Hemoperfusion on Microcirculation in Patients With Severe Sepsis and Septic Shock
Intensive Care Medicine Experimental
Critical Care
Intensive Care Medicine
A Case of Successful Treatment With Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion in Acute Respiratory Distress Syndrome After Influenza a Infection
Internal Medicine
Internal Medicine
Medicine
Continuous Hemodiafiltration With Polymyxin-B Immobilized Fiber Is Effective in Patients With Sepsis Syndrome and Acute Renal Failure
Therapeutic Apheresis and Dialysis
Hematology
Nephrology
Direct Intensive Care Costs of Severe Sepsis and Septic Shock Patients in Thailand
Critical Care
Critical Care
Intensive Care Medicine
Sepsis, Severe Sepsis and Septic Shock in Adults and Anaesthesia
Southern African Journal of Anaesthesia and Analgesia
Anesthesiology
Pain Medicine
